Active ingredients: Clindamycin

Product name and form

Clindamycin 150 mg capsules, hard.

Pharmaceutical Form


Clindamycin capsules are white/white hard capsules with a marking of ‘CLIN 150’ on the capsule body.

Qualitative and quantitative composition

Each capsule contains: clindamycin hydrochloride equivalent to 150 mg clindamycin.

Excipient with known effect: 214 mg lactose/Clindamycin 150 mg capsules.

For the full list of excipients, see section 6.1.

Active Ingredient

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

List of Excipients

Lactose monohydrate
Maize starch
Magnesium Stearate
Capsule shell
Titanium dioxide (E171)
Printing ink
Iron oxide black (E172)
Propylene glycol (E1520)

Pack sizes and marketing

The blister pack (PVC/aluminium) contains 24, 30, 32, 40 or 100 tablets, respectively.

Not all pack sizes may be marketed.

Marketing authorization holder

Rivopharm UK Ltd., 30th Floor, 40 Bank Street, Canary Wharf, London, El4 5NR, United Kingdom

Marketing authorization dates and numbers

PL 33155/0009